| Angiotensin-neprilysin inhibition versus enalapril in heart failure. ZMR McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR ... The New England Journal of Medicine 371 (11), 993-1004, 2014 | 8735* | 2014 |
| Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. G HF-Investigators Lancet (London, England) 372 (9645), 1223-30, 2008 | 1789 | 2008 |
| Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial TGHF Investigators Lancet 372 (1231-1239), 2008 | 1503 | 2008 |
| Vorapaxar in the secondary prevention of atherothrombotic events. MSA Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA ... N Engl J Med. 366 (15), 1404-13, 2012 | 1209* | 2012 |
| Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... Circulation 131 (1), 54-61, 2015 | 872 | 2015 |
| Acute pulmonary embolism and COVID-19 pneumonia: a random association? GB Danzi, M Loffi, G Galeazzi, E Gherbesi European heart journal 41 (19), 1858-1858, 2020 | 861 | 2020 |
| Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy SS Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C ... N Engl J Med 383 (5), 496-498, 2020 | 809* | 2020 |
| Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for … ZMR McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR ... Eur J Heart Fail. 15 (9), 1062-73, 0 | 584* | |
| ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes GG Stefanini, M Montorfano, D Trabattoni, D Andreini, G Ferrante, ... Circulation 141 (25), 2113-2116, 2020 | 583 | 2020 |
| Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine … PM Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B ... Circ Heart Fail. 9 (1), 2016 | 431 | 2016 |
| Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a … TMERTWCAA to Prevent Transluminal Coronary Obstruction and Restenosis ... Circulation. 86 (1), 100-10, 1992 | 423 | 1992 |
| Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short-and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler … PW Serruys, C Di Mario, J Piek, E Schroeder, C Vrints, P Probst, ... Circulation 96 (10), 3369-3377, 1997 | 390 | 1997 |
| COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests E Baldi, GM Sechi, C Mare, F Canevari, A Brancaglione, R Primi, C Klersy, ... European heart journal 41 (32), 3045-3054, 2020 | 331 | 2020 |
| Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart … TGHF investigators The European Journal of Heart Failure 6, 635-641, 2004 | 309 | 2004 |
| Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia R Ferraresi, M Centola, M Ferlini, R Da Ros, C Caravaggi, R Assaloni, ... European Journal of Vascular and Endovascular Surgery 37 (3), 336-342, 2009 | 290 | 2009 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 221 | 2020 |
| Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. PG Testa S, Prandoni P, Paoletti O, Morandini R, Tala M, Dellanoce C, Giorgi ... J Thromb Haemost. 2020 Jun;18(6):1320-1323. 18 (6), 1320-1323, 2020 | 210* | 2020 |
| Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study CM Lombardi, V Carubelli, A Iorio, RM Inciardi, A Bellasi, C Canale, ... JAMA cardiology 5 (11), 1274-1280, 2020 | 208 | 2020 |
| . Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global … MMJJ Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi ... Circulation, 2016 | 207 | 2016 |
| Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials M Valgimigli, G Biondi-Zoccai, M Tebaldi, AWJ van't Hof, G Campo, ... European Heart Journal 31 (1), 35-49, 2010 | 198 | 2010 |
John McMurrayUniversity of Glasgow.Verified email at glasgow.ac.uk
